CARISSA BEST: Open Payments
NPI 1225627912 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$987 in 39 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $854 · 2025 $987
Food & beverage: $987
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 10 | $272 |
| E.R. Squibb & Sons, L.L.C. | 5 | $269 |
| Neurocrine BioSciences, Inc. | 14 | $190 |
| Otsuka America Pharmaceutical, Inc. | 5 | $136 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| ABBVIE INC. | 1 | $34 |
| Corium, LLC | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
Products named: COBENFY, ABILIFY ASIMTUFII, INGREZZA, REXULTI, ABILIFY MAINTENA, Auvelity, VRAYLAR, Azstarys.
Industry payments across NY — which companies pay providers there.
